Lupin Ltd Drug Patent Portfolio

Lupin Ltd's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Lupin Ltd News

Upcoming expirations of GLP-1 drug patents attract generic manufacturers - C&EN

09 Dec, 2025

NCLAT rules that CCI is unable to investigate anti-competitive behavior related to patented medications - Bar and Bench

31 Oct, 2025

Boost for Indian pharmaceutical companies as US FDA relaxes regulations on biosimilar approvals.

31 Oct, 2025

ANDA Litigation Settlements for Q3 2025 | Robins Kaplan LLP - JDSupra

30 Oct, 2025

See More